Literature DB >> 25436796

The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer.

Ramón Rami-Porta1, Vanessa Bolejack, Dorothy J Giroux, Kari Chansky, John Crowley, Hisao Asamura, Peter Goldstraw.   

Abstract

The analyses of the retrospective database of the International Association for the Study of Lung Cancer (IASLC), consisting of more than 81,000 evaluable patients diagnosed with lung cancer between 1990 and 2000, formed the basis of recommendations to the Union for International Cancer Control and the American Joint Committee on Cancer for the revision of the sixth edition of the tumor, node, and metastasis (TNM) classification of lung cancer. However, despite the large number of patients, not all descriptors could be validated. This prompted a new collection of retrospective and prospective data to overcome the limitations of the original retrospective database. The new IASLC database has information on 94,708 new patients diagnosed of lung cancer between 1999 and 2010. They originated from 35 sources in 16 countries, and 4,667 were submitted via the online electronic data capture system. Europe contributed 46,560 patients, Asia: 41,705, North America: 4,660, Australia: 1,593, and South America: 190. After exclusions, 77,156 (70,967 with nonsmall cell lung cancer and 6,189 with small cell lung cancer) remained for analysis. This database will be analyzed according to established objectives for the T, the N, and the M components to inform the eighth edition of the TNM classification of lung cancer due to be published in 2016. The IASLC hopes for the continuing contribution of our partners around the world to improve the classification of anatomical extent of disease, but also to create prognostic groups in a parallel project of the IASLC Staging and Prognostic Factors Committee.

Entities:  

Mesh:

Year:  2014        PMID: 25436796     DOI: 10.1097/JTO.0000000000000334

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  84 in total

1.  Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools.

Authors:  Alyson L Mahar; Carolyn Compton; Lisa M McShane; Susan Halabi; Hisao Asamura; Ramon Rami-Porta; Patti A Groome
Journal:  J Thorac Oncol       Date:  2015-11       Impact factor: 15.609

Review 2.  The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications.

Authors:  Wanyin Lim; Carole A Ridge; Andrew G Nicholson; Saeed Mirsadraee
Journal:  Quant Imaging Med Surg       Date:  2018-08

Review 3.  Missed lung cancer: when, where, and why?

Authors:  Annemilia Del Ciello; Paola Franchi; Andrea Contegiacomo; Giuseppe Cicchetti; Lorenzo Bonomo; Anna Rita Larici
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

Review 4.  The 8th TNM edition for lung cancer: a critical analysis.

Authors:  Paul E Van Schil; Ramon Rami-Porta; Hisao Asamura
Journal:  Ann Transl Med       Date:  2018-03

5.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

6.  Searching for an arrow hitting two targets: the time to evaluate long-term outcomes of video-assisted thoracoscopic surgery lobectomy for early-stage lung cancer.

Authors:  Tomohito Saito; Tomohiro Murakawa
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

7.  Predicting the prognosis of lung cancer: the evolution of tumor, node and metastasis in the molecular age-challenges and opportunities.

Authors:  Ramón Rami-Porta; Hisao Asamura; Peter Goldstraw
Journal:  Transl Lung Cancer Res       Date:  2015-08

8.  [Pathological-anatomical diagnosis according to the German lung cancer guideline 2018].

Authors:  K Junker; R Büttner; T Langer; D Ukena
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

9.  Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors:  Gregory A Masters; Sarah Temin; Christopher G Azzoli; Giuseppe Giaccone; Sherman Baker; Julie R Brahmer; Peter M Ellis; Ajeet Gajra; Nancy Rackear; Joan H Schiller; Thomas J Smith; John R Strawn; David Trent; David H Johnson
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

Review 10.  Trends and current status of general thoracic surgery in Japan revealed by review of nationwide databases.

Authors:  Meinoshin Okumura
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.